Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

December 14, 2018

Bausch Health signs stalking horse agreement to buy Synergy Pharmaceuticals

Bausch Health Companies has signed an agreement to acquire certain assets of Synergy Pharmaceuticals in a transaction valued at around $200m plus certain assumed liabilities.

Bausch Health signs stalking horse agreement to buy Synergy Pharmaceuticals